[1]
X. Wen , Tran., “CRISPR-Based Gene Therapy for Type 2 Diabetic Neuropathy”, Eur. J. Public Health Environ. Res., vol. 2, no. 1, pp. 120–127, May 2026, doi: 10.71222/3kphhw81.